Gavish D, Brinton E A, Breslow J L
Rockefeller University, New York 10021.
Science. 1989 Apr 7;244(4900):72-6. doi: 10.1126/science.2565046.
Low-density lipoprotein (LDL) concentrations correlate with risk of coronary heart disease, and genetic variation affecting LDL levels influences atherosclerosis susceptibility. The principal LDL protein is apolipoprotein B (apoB); apoB is not exchangeable between lipoprotein particles and there is only one apoB per LDL particle. Plasma LDL therefore consists of two populations, one containing apoB derived from the maternal and one from the paternal apoB alleles. Products of the apob gene with high or low affinity for the MB-19 monoclonal antibody can be distinguished, and this antibody was used to identify heterozygotes with allele-specific differences in the amount of apoB in their plasma. A family study confirmed that the unequal expression phenotype was inherited in an autosomal dominant manner and was linked to the apob gene locus. Significant apoB genetic variation affecting plasma LDL levels may be more common than previously appreciated.
低密度脂蛋白(LDL)浓度与冠心病风险相关,影响LDL水平的基因变异会影响动脉粥样硬化易感性。主要的LDL蛋白是载脂蛋白B(apoB);apoB在脂蛋白颗粒之间不可交换,每个LDL颗粒仅含有一个apoB。因此,血浆LDL由两个群体组成,一个群体含有来自母本apoB等位基因的apoB,另一个群体含有来自父本apoB等位基因的apoB。可以区分对MB-19单克隆抗体具有高亲和力或低亲和力的载脂蛋白B(apob)基因产物,并且该抗体用于鉴定其血浆中apoB量存在等位基因特异性差异的杂合子。一项家族研究证实,这种不等表达表型以常染色体显性方式遗传,并与载脂蛋白B(apob)基因位点相关。影响血浆LDL水平的显著载脂蛋白B(apoB)基因变异可能比之前认为的更为常见。